The gunman who shot and killed an NYPD officer and three other people in midtown Manhattan on Monday carried a handwritten note claiming he had CTE — a degenerative brain disease that is the result of ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

BURLINGTON, Vt. (WCAX) - Vermont and the North Country are experiencing an impressive start to the winter season. Snow at the stake on Mount Mansfield hit 50 inches on Thursday, the earliest in the ...

Cam Skattebo started the year as a depth running back. Now, he is one of the faces of the franchise. At least, that appears to be how fans and the official NFL social media account is treating him.

Melbourne's multi-year pursuit of GWS forward Wade Derksen is set to come to fruition in the upcoming trade period. Derksen formally requested a trade to Victoria last year, but the Giants, amid a ...

It isn’t yet possible to diagnose chronic traumatic encephalopathy—more widely known as CTE—in the living. Yet for many people, especially athletes, the fear is real. In fact, 1 in 3 former NFL ...